Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in VIR held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 18.0M | $161.3M | +10.2% | 11.163% | 0.00% |
| 2 | ARCH Venture Management, LLC | 12.9M | $115.7M | 0.0% | 8.011% | 17.09% |
| 3 | SB INVESTMENT ADVISERS (UK) LTD | 10.9M | $98.1M | -16.5% | 6.790% | 1.27% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 9.2M | $82.6M | β | 5.716% | 0.00% |
| 5 | GSK plc | 8.6M | $76.6M | 0.0% | 5.303% | 12.79% |
| 6 | STATE STREET CORP | 7.1M | $64.0M | +14.6% | 4.429% | 0.00% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 5.4M | $48.2M | β | 3.338% | 0.00% |
| 8 | GOLDMAN SACHS GROUP INC | 3.3M | $29.1M | +107.2% | 2.016% | 0.00% |
| 9 | MORGAN STANLEY | 2.9M | $25.6M | +6.5% | 1.770% | 0.00% |
| 10 | ADAR1 Capital Management, LLC | 2.7M | $24.6M | β | 1.702% | 1.54% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 2.7M | $23.8M | +14.2% | 1.648% | 0.00% |
| 12 | DIMENSIONAL FUND ADVISORS LP | 2.6M | $23.1M | +1.7% | 1.600% | 0.00% |
| 13 | CITADEL ADVISORS LLC | 2.2M | $19.7M | +305.2% | 1.367% | 0.01% |
| 14 | FMR LLC | 2.1M | $18.6M | -34.4% | 1.285% | 0.00% |
| 15 | Soleus Capital Management, L.P. | 2.0M | $17.9M | β | 1.242% | 0.73% |
| 16 | Point72 Asset Management, L.P. | 2.0M | $17.5M | +897.5% | 1.211% | 0.02% |
| 17 | Boxer Capital Management, LLC | 1.9M | $16.7M | +198.6% | 1.157% | 2.20% |
| 18 | GordonMD Global Investments LP | 1.5M | $13.6M | +63.2% | 0.942% | 9.48% |
| 19 | Sio Capital Management, LLC | 1.5M | $13.4M | +213.3% | 0.929% | 1.94% |
| 20 | Pictet Asset Management Holding SA | 1.5M | $13.3M | +10878.9% | 0.918% | 0.01% |
| 21 | Hudson Bay Capital Management LP | 1.5M | $13.2M | +10.9% | 0.911% | 0.14% |
| 22 | JACOBS LEVY EQUITY MANAGEMENT, INC | 1.4M | $12.9M | β | 0.895% | 0.05% |
| 23 | TWO SIGMA INVESTMENTS, LP | 1.4M | $12.9M | +144.2% | 0.893% | 0.01% |
| 24 | Qube Research & Technologies Ltd | 1.2M | $11.2M | +1403.3% | 0.774% | 0.01% |
| 25 | Clearstead Advisors, LLC | 1.2M | $10.9M | β | 0.754% | 0.10% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in VIR β a direct measure of their conviction.
Filings activity in VIR during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new VIR position in Q1 2026
Institutions that fully closed their VIR position in Q1 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 248 | +15% | 88.58% | +38.84 pp | $1.23B | +78% |
| Q4 2025 | 216 | +4.3% | 49.74% | +6.07 pp | $691M | +14% |
| Q3 2025 | 207 | 1.4% | 43.67% | +3.83 pp | $606M | +9.6% |
| Q2 2025 | 210 | 8.7% | 39.84% | 2.63 pp | $553M | 6.2% |
| Q1 2025 | 230 | +11% | 42.47% | 3.24 pp | $590M | 7.1% |
| Q4 2024 | 208 | +7.8% | 45.71% | 1.33 pp | $635M | 2.8% |
| Q3 2024 | 193 | 9.8% | 47.04% | 9.08 pp | $653M | 16% |
| Q2 2024 | 214 | β | 56.12% | β | $779M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying VIR stock.
Based on Q1 2026 13F filings, institutional ownership of Vir Biotechnology, Inc. stands at 88.6%, held across 248 reporting institutions.
BlackRock, Inc. is the largest reported institutional holder of VIR, with approximately 17,998,329 shares worth $0.16B as of Q1 2026.
Yes β 3 widely-followed marquee investors appear among the top 25 institutional holders of VIR, including CITADEL ADVISORS LLC, Point72 Asset Management, L.P., TWO SIGMA INVESTMENTS, LP.
Our composite Smart Money Score for VIR is 79 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
71 institutions opened new positions in VIR during Q1 2026, while 39 fully exited. 158 added to existing positions and 18 trimmed.
VIR institutional ownership rose by 38.84 percentage points quarter-over-quarter, with a net change of +32 holders.
The top 10 institutions account for 59.0% of all reported 13F value in VIR, and the top 25 account for 78.4%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Vir Biotechnology, Inc. (VIR) Institutional Ownership